Donna Holder is the Senior Director, Global MSL Excellence at Daiichi Sankyo Inc (DSI) where she is accountable for ensuring the strategic alignment of MSL activities across DSI regions, and for strengthening the MSL capability worldwide. Donna has over 25 years of experience in the pharmaceutical industry with a wealth of experience in Medical Affairs. Most recently she was the Executive Director, Global Field Medical Center of Excellence (CoE) at Merck from January 2018 to May 2020 where she was responsible for the Field Medical capability worldwide along with the leadership of scientific and capability training function for Field Medical.
She started her career at Marion Merrell Dow (now Sanofi) in Clinical Development and then joined AstraMerck (now AstraZeneca Pharmaceuticals) where she spent over ten years in senior leadership roles including leadership of MSL, Medical Information, and Contact Center teams. In her last role at AZ as Senior Director, MSL Excellence in Global Medical Affairs, Donna was accountable for the strategic direction of the MSL function. She led development, delivery, and measurement of initiatives to strengthen MSL capabilities worldwide. Donna left AZ at the end of 2014 and became a Medical Affairs consultant, partnering with pharmaceutical and biotech clients to deliver solutions including capability development, business process development, business strategy, operations management, and coaching. Donna earned her Doctor of Pharmacy from the University of Michigan.
Ralph Rewers is currently the Sr. Director, Head Global MSL Excellence – Oncology at AstraZeneca.
Prior to that he led the global field excellence for Abbvie and had overall responsibility for operational and foundational skill support of global MSLs. Prior to that he led the Abbvie US MSL team across 9 therapeutic areas. He also led the launch of the Global Field Medical team for the oncology portfolio..
Ralph has over 27 years of field medical experience starting as an MSL for Pfizer in Denver, CO. He worked in many therapeutic areas at Pfizer and taken on roles of increasing responsibility including field manager and HQ group leader responsibilities.
After 13 years at Pfizer, Ralph joined Amgen as the executive director for US oncology field medical. In his 5 years at Amgen he took on additional leadership roles culminating in his overall leadership of the field medical function for all therapeutic areas.
Prior to that he was the director of oncology field medical sciences at Bristol Myers Squibb where he led a group of US MSLs in support of 4 marketed and 3 late stage pipeline products.
Prior to industry Ralph spent 13 years in clinical practice, focusing on critical care medicine. Ralph received his BS and PharmD from Purdue University. He currently resides in Aurora, CO.